Premium
EFFICIENCY AND SAFETY OF STEM CELL MOBILIZATION FOLLOWING GDP SALVAGE IN PATIENTS WITH RELAPSED OR REFRACTORY LYMPHOMA
Author(s) -
Tang C.,
EspinGarcia O.,
Prica A.,
Kukreti V.,
Kridel R.,
Keating A.,
Kuruvilla J.,
Crump M.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.112_2631
Subject(s) - medicine , plerixafor , apheresis , leukapheresis , etoposide , granulocyte colony stimulating factor , neutropenia , gemcitabine , regimen , surgery , urology , chemotherapy , cd34 , stem cell , cxcr4 , platelet , chemokine , receptor , biology , genetics